MENU
+Compare
SLNO
Stock ticker: NASDAQ
AS OF
Jan 17 closing price
Price
$46.88
Change
+$0.89 (+1.94%)
Capitalization
2.02B

SLNO Soleno Therapeutics Forecast, Technical & Fundamental Analysis

a developer of medical diagnostics and therapeutics based on its proprietary technology for precision metering of gas flow

Industry Biotechnology
SLNO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for SLNO with price predictions
Jan 08, 2025

SLNO in +3.36% Uptrend, rising for three consecutive days on January 03, 2025

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where SLNO advanced for three days, in of 244 cases, the price rose further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where SLNO's RSI Oscillator exited the oversold zone, of 34 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for SLNO just turned positive on December 30, 2024. Looking at past instances where SLNO's MACD turned positive, the stock continued to rise in of 51 cases over the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 57 cases where SLNO's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

The Momentum Indicator moved below the 0 level on January 08, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on SLNO as a result. In of 82 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SLNO declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for SLNO entered a downward trend on December 31, 2024. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. SLNO’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SLNO’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock better than average.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (7.634) is normal, around the industry mean (14.746). P/E Ratio (0.000) is within average values for comparable stocks, (88.252). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.853). SLNO has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.013). P/S Ratio (0.000) is also within normal values, averaging (264.084).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

View a ticker or compare two or three
SLNO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

SLNO is expected to report earnings to fall 45.36% to -100 cents per share on March 25

Soleno Therapeutics SLNO Stock Earnings Reports
Q4'24
Est.
$-1.00
Q3'24
Missed
by $1.22
Q2'24
Beat
by $0.02
Q1'24
Missed
by $0.22
Q4'23
Missed
by $0.06
The last earnings report on November 06 showed earnings per share of -183 cents, missing the estimate of -61 cents. With 348.37K shares outstanding, the current market capitalization sits at 2.02B.
A.I. Advisor
published General Information

General Information

a developer of medical diagnostics and therapeutics based on its proprietary technology for precision metering of gas flow

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
203 Redwood Shores Parkway
Phone
+1 650 213-8444
Employees
42
Web
https://www.soleno.life
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VRGWX805.199.85
+1.24%
Vanguard Russell 1000 Growth Index I
JLPSX21.580.23
+1.08%
JPMorgan US Large Cap Core Plus I
GTTTX33.08N/A
N/A
Goldman Sachs Small Cp Val Insghts Inv
HRLRX8.53N/A
N/A
Hartford Real Asset R3
FEQDX13.11N/A
N/A
Fidelity Advisor Hedged Equity Fund C

SLNO and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, SLNO has been loosely correlated with BRNS. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if SLNO jumps, then BRNS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SLNO
1D Price
Change %
SLNO100%
+1.94%
BRNS - SLNO
56%
Loosely correlated
+2.97%
KANT - SLNO
45%
Loosely correlated
N/A
KYMR - SLNO
43%
Loosely correlated
+0.79%
XENE - SLNO
40%
Loosely correlated
-2.78%
ACLX - SLNO
40%
Loosely correlated
-0.79%
More

Groups containing SLNO

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SLNO
1D Price
Change %
SLNO100%
+1.94%
gas flow
theme (2 stocks)
96%
Closely correlated
+1.07%